Matthew Stachler

13PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersPsychopharmacologyCancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 27, 2026
Histopathology-Based Spatial Profiling of Immune and Molecular Features Predicts Cancer Risk in Barrett's Esophagus Patients.

|Feb 25, 2026
Adjunctive Use of p53 Immunohistochemistry for Risk Stratification in Barrett's Esophagus: A Systematic Review and Meta-Analysis.

Tarek Sawas, Perica Davitkov, Margaret Zhou

|Nov 26, 2025
Histopathology-based Spatial Profiling of Immune and Molecular Features Predicts Cancer risk in Barrett's Esophagus.

Caner Ercan, Xiaoxi Pan, Thomas G Paulson

|Apr 16, 2025
Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity.

Kai R Trepka, Wesley A Kidder, Than S Kyaw

|Jan 31, 2025
Does radiofrequency ablation of the lower oesophagus allow for clonal expansion of highly mutated neosquamous epithelium?

Fahire Goknur Akarca, Nicholas J Shaheen, Matthew D Stachler

|Jul 15, 2024
Molecular Analysis of Persistent and Recurrent Barrett's Esophagus in the Setting of Endoscopic Therapy.

Aarti Kumar, Marianne Rara, Ming Yu

Pageof 3

Frequent Collaborators

2 joint publications

William M Grady

2 joint publications

Carlo C Maley

2 joint publications

Fahire Göknur Akarca

2 joint publications

Qurat-Ul-Ain